focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Net Asset Value

24 Feb 2022 13:30

Net Asset Value

Oxford Technology 2 VCT Plc – NAV Update

Oxford Technology 2 VCT Plc (“OT2”) announces an update to the unaudited Net Asset Value (“NAV”) of the Company from the third quarter figures issued to 30 November 2021, based on movements in its AIM quoted investments and an estimate of running costs.

As at 23 February 2022 the NAV has fallen by 10% from 34.9p to 31.5p.

This share price of both quoted stocks has fallen - Arecor Therapeutics Plc (“Arecor”) (380p to 350p) and Scancell Holdings Plc (“Scancell”) (20p to 13p).

The valuations of the other holdings have been left unchanged for the purposes of this NAV update. Fuller results for the 12 month period ending on 28 February 2022 will be announced in due course.

Shareholders should note that for every 10p per share change in Arecor’s bid price, the NAV moves by about 0.5p per OT2 share.

The total number of ordinary shares in issue is 5,331,889.

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, this information is now considered to be in the public domain.

24 February 2022

Enquiries: Lucius Cary Oxford Technology Management 01865 784466

LEI: 213800TXRQEIU31IP105

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.